Nyu Langone Hospitals

Nyu Langone Hospitals was paid $238.69M by Medicaid between Jan 2018 and Dec 2024, across 848 billing codes. Its largest line is G0378, Hospital observation service, per hour — 4.3% of everything it billed.

33Billing provider infoNYU LANGONE HOSPITALS
NEW YORK, NY 10016

33aNPI1801992631assigned 09/16/2006

33bProvider typeOncology Clinic/Center

28Total paid$238.69M

24GClaims4,685,853

24DCodes billed848

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Oncology Clinic/Center providers in New York

Rank by total paid#1 of 6

Median peer was paid$199K

This provider vs. median1,197×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	130,056	$2.08M
2019	349,297	$13.03M
2020	848,976	$32.27M
2021	1,124,411	$44.98M
2022	725,160	$44.44M
2023	753,712	$54.22M
2024incomplete	754,241	$47.67M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0378	Hospital observation service, per hour	4.3%	8,593	8,111	$10.32M
J3380	Injection, vedolizumab, intravenous, 1 mg	4.2%	1,662	1,528	$10.11M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.6%	34,803	32,405	$8.70M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.4%	37,456	35,389	$8.09M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	3.0%	40,426	38,296	$7.23M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	3.0%	10,274	10,165	$7.09M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	2.5%	1,529	1,216	$6.03M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	2.5%	37,833	33,573	$5.88M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.5%	69,961	26,879	$5.85M
45380	Colonoscopy, flexible; with biopsy, single or multiple	2.4%	7,209	7,131	$5.75M
C1889	Implantable/insertable device, not otherwise classified	2.4%	17,347	15,384	$5.67M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.1%	19,763	16,647	$4.96M

836 more codes

96361	Intravenous infusion, hydration; each additional hour	1.9%	21,914	$4.61M
93458		1.8%	2,403	$4.40M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.6%	19,245	$3.76M
J9271	Injection, pembrolizumab, 1 mg	1.4%	405	$3.32M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	12,653	$2.99M
C1874	Stent, coated/covered, with delivery system	1.2%	1,230	$2.76M
J2323	Injection, natalizumab, 1 mg	1.1%	355	$2.55M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.1%	1,676	$2.53M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.1%	13,677	$2.51M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	1.0%	3,107	$2.47M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	32,898	$2.36M
93454		<1%	1,300	$2.22M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,484	$2.13M
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	1,305	$2.11M
J2350	Injection, ocrelizumab, 1 mg	<1%	67	$2.06M
C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	<1%	1,112	$2.03M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	8,111	$1.93M
80053	Comprehensive metabolic panel	<1%	184,723	$1.86M
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	3,495	$1.86M
70450	Computed tomography, head or brain; without contrast material	<1%	7,965	$1.80M
93320		<1%	5,638	$1.78M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	84,686	$1.70M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	9,140	$1.63M
67311		<1%	748	$1.49M
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	18,593	$1.46M
97161		<1%	12,407	$1.45M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,002	$1.42M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	10,364	$1.39M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	9,916	$1.36M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	56,385	$1.34M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	56,460	$1.30M
96415		<1%	3,527	$1.28M
80050	General health panel	<1%	39,135	$1.28M
C1769	Guide wire	<1%	7,173	$1.28M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	979	$1.26M
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	44,312	$1.25M
10E0XZZ		<1%	1,461	$1.22M
93975		<1%	2,986	$1.20M
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	700	$1.15M
80061	Lipid panel	<1%	123,064	$1.13M
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,037	$1.12M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	724	$1.12M
86480		<1%	21,166	$1.06M
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	12,069	$1.02M
84443	Thyroid stimulating hormone (TSH)	<1%	77,576	$1.01M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	397	$997K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	27,321	$972K
C1732	Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping	<1%	173	$955K
95708		<1%	2,442	$929K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	247,377	$918K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	212	$865K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	812	$861K
80048	Basic metabolic panel (calcium, ionized)	<1%	94,086	$852K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,632	$829K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	645	$811K
C1760	Closure device, vascular (implantable/insertable)	<1%	2,195	$791K
76825		<1%	2,598	$746K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	43,484	$734K
80076		<1%	54,955	$732K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	10,043	$728K
J3490	Unclassified drugs	<1%	57,192	$725K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	3,304	$712K
86769		<1%	19,035	$693K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	3,792	$650K
93017		<1%	7,010	$649K
95816		<1%	1,980	$629K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	4,395	$625K
83036	Hemoglobin; glycosylated (A1C)	<1%	99,717	$624K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,036	$582K
86900		<1%	21,678	$580K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	20,254	$569K
82607		<1%	46,734	$568K
93970		<1%	2,126	$563K
93976		<1%	1,410	$528K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,179	$513K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	21,020	$512K
87497		<1%	12,496	$487K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,295	$485K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	6,179	$484K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,969	$475K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	25,569	$457K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	918	$444K
J1756	Injection, iron sucrose, 1 mg	<1%	4,948	$440K
96375	Therapeutic injection; each additional sequential IV push	<1%	20,609	$432K
C1766	Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away	<1%	786	$427K
88342		<1%	8,901	$425K
88185		<1%	3,442	$417K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	28,975	$410K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,637	$399K
86803		<1%	36,404	$399K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	21,754	$391K
84439		<1%	54,428	$390K
42830		<1%	251	$388K
86850		<1%	21,682	$387K
76641		<1%	3,966	$384K
96450		<1%	642	$377K
J0485	Injection, belatacept, 1 mg	<1%	238	$374K
29580		<1%	2,157	$366K
94060		<1%	2,466	$363K
81507		<1%	794	$354K
83970		<1%	7,675	$354K
78815	Positron emission tomography (PET) for limited area imaging	<1%	259	$344K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	22,973	$336K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	13,086	$335K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	9,433	$332K
82728		<1%	32,321	$329K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	4,259	$320K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,803	$318K
J0185	Injection, aprepitant, 1 mg	<1%	1,047	$314K
96900		<1%	5,925	$314K
76770		<1%	1,307	$313K
97162		<1%	2,182	$312K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,713	$298K
95700		<1%	1,812	$295K
93325		<1%	8,834	$288K
C1753	Catheter, intravascular ultrasound	<1%	283	$280K
87481		<1%	4,181	$278K
88307		<1%	3,099	$275K
87536		<1%	3,616	$268K
82746		<1%	23,381	$264K
86235		<1%	6,053	$263K
36430		<1%	909	$262K
97165		<1%	2,907	$261K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	1,193	$259K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	826	$249K
86003		<1%	4,724	$247K
86901		<1%	21,605	$243K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	715	$235K
97116		<1%	2,649	$234K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,674	$230K
87799		<1%	4,243	$228K
87507		<1%	1,206	$228K
36415	Collection of venous blood by venipuncture	<1%	78,742	$223K
90834	Psychotherapy session, about 45 minutes	<1%	1,670	$222K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	<1%	65	$218K
93880		<1%	1,399	$213K
J7030	Infusion, normal saline solution , 1000 cc	<1%	38,496	$213K
31624		<1%	301	$211K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	3,015	$211K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	12,676	$210K
77336		<1%	523	$210K
J0583	Injection, bivalirudin, 1 mg	<1%	1,326	$209K
81001		<1%	78,401	$209K
83516		<1%	12,096	$207K
62323		<1%	316	$207K
83880		<1%	9,379	$205K
84403		<1%	8,624	$205K
88184		<1%	3,246	$204K
11102		<1%	378	$204K
94726		<1%	2,485	$202K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	3,324	$199K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	15,412	$197K
86780		<1%	20,813	$196K
86706		<1%	22,961	$195K
87340		<1%	25,865	$193K
97535	Self-care/home management training, each 15 minutes	<1%	1,884	$193K
82803		<1%	14,596	$193K
99213	Doctor's office visit, returning patient (routine)	<1%	1,810	$189K
76830	Ultrasound, transvaginal	<1%	3,912	$188K
10005		<1%	320	$186K
84153		<1%	13,044	$183K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	39,213	$181K
76536		<1%	1,977	$180K
87086	Culture, bacterial; quantitative colony count, urine	<1%	33,721	$180K
85027		<1%	38,361	$179K
J0897	Injection, denosumab, 1 mg	<1%	83	$178K
83655		<1%	13,623	$177K
92526		<1%	1,047	$175K
94010		<1%	2,946	$172K
88341		<1%	3,505	$168K
82784		<1%	14,164	$168K
77300		<1%	497	$166K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	16,625	$164K
82670		<1%	6,445	$163K
59025	Fetal non-stress test	<1%	1,868	$163K
87517		<1%	4,052	$162K
C1781	Mesh (implantable)	<1%	216	$160K
71250		<1%	1,496	$160K
11900		<1%	463	$157K
87522	Neg quan hep c or qual rna	<1%	4,274	$156K
83540		<1%	33,849	$154K
83550		<1%	27,411	$153K
J7050	Infusion, normal saline solution, 250 cc	<1%	31,107	$151K
99201		<1%	1,796	$149K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,293	$147K
93971		<1%	2,033	$145K
80197		<1%	15,456	$145K
83001		<1%	8,679	$143K
84146		<1%	8,140	$142K
A9585	Injection, gadobutrol, 0.1 ml	<1%	4,932	$140K
83735		<1%	42,171	$139K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	1,047	$138K
93451		<1%	86	$138K
93304		<1%	543	$137K
77334		<1%	443	$135K
77066	Tomosynthesis, mammo	<1%	1,153	$133K
86762		<1%	10,597	$132K
77063	Screening digital breast tomosynthesis, bilateral	<1%	5,290	$130K
31575		<1%	453	$130K
86765		<1%	11,482	$129K
83520		<1%	5,718	$128K
84270		<1%	5,609	$128K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,649	$127K
12001		<1%	324	$127K
10060		<1%	378	$124K
83002		<1%	7,663	$124K
C1776	Joint device (implantable)	<1%	12	$124K
76000		<1%	2,007	$123K
0002A		<1%	3,368	$123K
95800		<1%	600	$121K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	3,297	$120K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,756	$120K
77065	Tomosynthesis, mammo	<1%	1,237	$117K
83013		<1%	1,854	$117K
86787		<1%	11,941	$116K
86360		<1%	2,846	$116K
86160		<1%	7,842	$116K
J2327	Injection, risankizumab-rzaa, intravenous, 1 mg	<1%	13	$114K
0001A		<1%	3,748	$113K
84702		<1%	18,904	$113K
86140		<1%	32,811	$112K
86704		<1%	12,815	$112K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	42,876	$111K
J2704	Injection, propofol, 10 mg	<1%	50,955	$108K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	2,132	$107K
84481		<1%	8,778	$104K
87070		<1%	19,254	$104K
70496		<1%	482	$100K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	511	$98K
96417		<1%	2,365	$96K
93350		<1%	986	$95K
86376		<1%	7,628	$94K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	1,255	$94K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	11,175	$94K
76642		<1%	1,217	$93K
86735		<1%	8,446	$92K
82248		<1%	17,240	$92K
86200		<1%	5,899	$92K
V2632	Posterior chamber intraocular lens	<1%	548	$90K
92978		<1%	344	$90K
82627		<1%	4,639	$89K
84445		<1%	1,685	$89K
76827		<1%	2,591	$89K
92610		<1%	618	$89K
77080		<1%	1,667	$88K
96367		<1%	1,480	$86K
86147		<1%	2,378	$84K
82570		<1%	18,547	$82K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	2,893	$79K
J1437	Injection, ferric derisomaltose, 10 mg	<1%	25	$78K
93613		<1%	51	$78K
83021		<1%	4,972	$78K
84100		<1%	21,085	$77K
86800		<1%	6,123	$77K
C1726	Catheter, balloon dilatation, non-vascular	<1%	173	$76K
84480		<1%	8,441	$76K
85610		<1%	32,771	$75K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	414	$75K
49083		<1%	125	$75K
86334		<1%	3,672	$74K
49650		<1%	29	$73K
97166		<1%	502	$73K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	5,202	$72K
82105		<1%	6,929	$72K
86225		<1%	8,586	$72K
86695		<1%	4,918	$71K
71046	Radiologic examination, chest; 2 views	<1%	18,869	$71K
17110		<1%	133	$71K
58558		<1%	49	$70K
87511		<1%	1,993	$70K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,069	$69K
86696		<1%	4,944	$69K
97802		<1%	1,141	$68K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	<1%	15	$68K
97803		<1%	1,697	$68K
86359		<1%	2,508	$67K
82043		<1%	14,618	$67K
93798		<1%	857	$67K
82024		<1%	1,821	$66K
88112		<1%	1,731	$66K
81401		<1%	640	$66K
C1731	Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)	<1%	28	$65K
76942		<1%	490	$65K
93925		<1%	762	$65K
0004A		<1%	1,758	$65K
45381		<1%	130	$64K
87186		<1%	10,458	$63K
74230		<1%	477	$63K
85730		<1%	22,427	$62K
70486		<1%	894	$61K
86708		<1%	5,995	$60K
83615		<1%	16,697	$59K
85652		<1%	32,087	$59K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,886	$59K
86146		<1%	1,953	$59K
97035		<1%	2,966	$59K
12011		<1%	153	$58K
86038		<1%	7,271	$58K
J3535	Drug administered through a metered dose inhaler	<1%	2,367	$58K
96416		<1%	177	$58K
84154		<1%	3,443	$55K
81514		<1%	522	$55K
86790		<1%	3,208	$55K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	2,266	$55K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,425	$54K
80081		<1%	700	$54K
C1759	Catheter, intracardiac echocardiography	<1%	14	$54K
82550		<1%	9,108	$53K
83883		<1%	2,662	$52K
72125	Computed tomography, cervical spine; without contrast material	<1%	1,443	$52K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	329	$51K
86592		<1%	17,630	$51K
95886		<1%	863	$51K
88360		<1%	800	$50K
74183		<1%	186	$50K
94729		<1%	1,785	$50K
82378		<1%	3,932	$47K
84425		<1%	2,841	$47K
84550		<1%	12,628	$47K
87077		<1%	6,406	$47K
88304		<1%	2,031	$46K
82533		<1%	3,128	$46K
96402		<1%	663	$45K
86618		<1%	2,994	$44K
67312		<1%	27	$44K
70491		<1%	171	$43K
95911		<1%	244	$43K
86617		<1%	2,615	$42K
84402		<1%	1,632	$41K
90715		<1%	1,908	$40K
84432		<1%	2,306	$40K
86665		<1%	2,142	$40K
84305		<1%	2,474	$39K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	1,058	$39K
82785		<1%	3,312	$39K
84436		<1%	9,591	$39K
84165		<1%	4,877	$39K
C1714	Catheter, transluminal atherectomy, directional	<1%	287	$38K
83498		<1%	1,512	$38K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	17,987	$37K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	709	$37K
86923		<1%	1,166	$37K
87631		<1%	922	$36K
86747		<1%	2,322	$36K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,273	$36K
86357		<1%	1,262	$36K
82088		<1%	939	$35K
81003		<1%	27,713	$35K
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,608	$35K
82948		<1%	28,613	$34K
88313		<1%	1,159	$34K
93623		<1%	41	$34K
86039		<1%	4,515	$33K
95953		<1%	101	$33K
86355		<1%	1,143	$33K
87493		<1%	1,305	$32K
86812		<1%	1,108	$32K
88141		<1%	3,039	$32K
82652		<1%	942	$31K
76098		<1%	126	$31K
87081		<1%	6,287	$31K
86255		<1%	3,174	$31K
86021		<1%	2,032	$30K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	31,753	$30K
77295		<1%	86	$30K
36591		<1%	596	$30K
86694		<1%	1,977	$30K
0124A		<1%	707	$30K
87660		<1%	1,842	$29K
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	<1%	4,964	$28K
86256		<1%	1,118	$28K
95812		<1%	100	$28K
84144		<1%	1,405	$27K
30140		<1%	13	$27K
83690		<1%	22,301	$27K
67314		<1%	48	$27K
86300		<1%	1,663	$26K
C1729	Catheter, drainage	<1%	407	$26K
84703		<1%	24,749	$26K
86430		<1%	5,222	$26K
86707		<1%	2,642	$25K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	24,647	$25K
82977		<1%	5,181	$25K
77386		<1%	141	$25K
85613		<1%	1,930	$24K
72141		<1%	128	$24K
88108		<1%	679	$24K
87510		<1%	1,578	$24K
82274		<1%	2,655	$24K
87480		<1%	1,541	$23K
87350		<1%	2,451	$23K
72131		<1%	203	$23K
84207		<1%	879	$23K
99203	Doctor's office visit, new patient (routine)	<1%	185	$22K
84484		<1%	19,639	$22K
81513		<1%	460	$22K
82164		<1%	1,474	$22K
82951		<1%	2,581	$22K
84156		<1%	7,587	$22K
86664		<1%	1,896	$22K
83695		<1%	1,652	$22K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	564	$22K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	3,711	$22K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	164	$21K
81243		<1%	657	$21K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	24,139	$21K
82085		<1%	1,546	$21K
64644		<1%	49	$21K
84681		<1%	1,138	$20K
87512		<1%	502	$20K
87329		<1%	2,046	$20K
73562		<1%	1,573	$19K
86663		<1%	1,943	$19K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,384	$19K
85240		<1%	1,499	$19K
82985		<1%	1,565	$19K
83921		<1%	1,020	$19K
88312		<1%	901	$19K
86141		<1%	1,794	$19K
95913		<1%	100	$19K
84244		<1%	835	$19K
83993		<1%	1,317	$18K
96401		<1%	269	$18K
86777		<1%	1,412	$18K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	19,376	$18K
86778		<1%	1,411	$18K
64642		<1%	26	$18K
73564		<1%	1,610	$17K
87177		<1%	2,137	$17K
87338		<1%	1,813	$17K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,275	$17K
73630		<1%	2,461	$17K
0054A		<1%	440	$17K
86304		<1%	1,464	$17K
77002		<1%	72	$17K
82397		<1%	1,536	$16K
83010		<1%	1,769	$16K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	75	$16K
82157		<1%	615	$16K
87147		<1%	3,546	$16K
86335		<1%	496	$16K
J1815	Injection, insulin, per 5 units	<1%	3,341	$16K
81329		<1%	172	$16K
93656		<1%	14	$16K
87205		<1%	6,412	$16K
90677		<1%	78	$15K
80069		<1%	1,986	$15K
85379		<1%	5,868	$15K
86431		<1%	3,161	$15K
86644		<1%	1,267	$15K
87045		<1%	2,068	$15K
96411		<1%	283	$14K
80074		<1%	386	$14K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	24	$14K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	902	$14K
83525		<1%	1,387	$14K
86645		<1%	1,399	$14K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,195	$14K
88142		<1%	768	$14K
73030		<1%	1,845	$14K
73130		<1%	1,995	$14K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	2,362	$14K
82150		<1%	3,002	$13K
0003A		<1%	365	$13K
80177		<1%	1,516	$13K
86709		<1%	1,599	$13K
93308		<1%	69	$13K
82610		<1%	899	$13K
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,264	$13K
L8699	Prosthetic implant, not otherwise specified	<1%	12	$13K
88262		<1%	151	$12K
71045	Radiologic examination, chest; single view	<1%	5,854	$12K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	34	$12K
83721		<1%	3,288	$12K
86885		<1%	124	$12K
72156		<1%	72	$12K
90686		<1%	972	$12K
86317		<1%	219	$12K
83521		<1%	97	$12K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	115	$12K
87102		<1%	2,054	$12K
87209		<1%	1,075	$12K
76870		<1%	609	$12K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,276	$12K
72100		<1%	669	$11K
87328		<1%	1,060	$11K
J1644	Injection, heparin sodium, per 1000 units	<1%	9,134	$11K
84460		<1%	2,873	$11K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	27,452	$11K
86364		<1%	430	$11K
84479		<1%	2,817	$11K
82950		<1%	2,495	$11K
93505		<1%	24	$10K
82668		<1%	708	$10K
81376		<1%	216	$10K
85045		<1%	4,641	$10K
54161		<1%	12	$10K
87116		<1%	1,626	$10K
80164		<1%	955	$10K
64493		<1%	15	$10K
78306		<1%	47	$10K
81383		<1%	176	$10K
82103		<1%	849	$10K
82390		<1%	1,154	$10K
83835		<1%	600	$10K
86301		<1%	816	$9K
74174		<1%	111	$9K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,058	$9K
73110		<1%	1,395	$9K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	382	$9K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	48	$9K
J9190	Injection, fluorouracil, 500 mg	<1%	212	$9K
64643		<1%	85	$9K
87272		<1%	827	$9K
70498		<1%	301	$9K
73610		<1%	1,979	$8K
83951		<1%	148	$8K
73502		<1%	1,030	$8K
93312		<1%	169	$8K
86671		<1%	438	$8K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	435	$8K
87106		<1%	840	$8K
87075		<1%	1,449	$8K
90662		<1%	191	$8K
93321		<1%	816	$8K
80175		<1%	776	$8K
84075		<1%	1,998	$8K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,023	$8K
84466		<1%	790	$7K
84630		<1%	847	$7K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,515	$7K
G0008	Administration of influenza virus vaccine	<1%	399	$7K
87632		<1%	160	$7K
86705		<1%	802	$7K
84446		<1%	617	$7K
83090		<1%	459	$7K
90472	Immunization administration, each additional vaccine (list separately)	<1%	670	$7K
85670		<1%	1,734	$7K
86682		<1%	680	$7K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	54	$7K
86341		<1%	382	$7K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,725	$7K
80305		<1%	2,622	$7K
87653		<1%	263	$7K
82310		<1%	1,948	$7K
95076		<1%	14	$7K
75574		<1%	53	$7K
88237		<1%	77	$7K
84590		<1%	702	$7K
94760		<1%	1,983	$7K
82172		<1%	402	$7K
84450		<1%	2,408	$7K
J9045	Injection, carboplatin, 50 mg	<1%	124	$6K
85306		<1%	500	$6K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,712	$6K
86870		<1%	70	$6K
82247		<1%	2,412	$6K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	4,514	$6K
J3250	Injection, trimethobenzamide hcl, up to 200 mg	<1%	361	$6K
84155		<1%	2,863	$6K
82565		<1%	1,976	$6K
85732		<1%	1,135	$6K
76826		<1%	43	$6K
88172		<1%	309	$6K
78451		<1%	14	$6K
80299		<1%	389	$6K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	2,774	$6K
38222		<1%	13	$5K
87899		<1%	758	$5K
82955		<1%	569	$5K
20553		<1%	26	$5K
S0028	Injection, famotidine, 20 mg	<1%	6,025	$5K
87040		<1%	4,792	$5K
82140		<1%	303	$5K
85384		<1%	1,218	$5K
87634		<1%	183	$5K
82232		<1%	382	$5K
96376		<1%	3,041	$5K
86666		<1%	408	$5K
82787		<1%	209	$5K
78264		<1%	24	$5K
81450		<1%	113	$5K
82040		<1%	1,853	$5K
C1758	Catheter, ureteral	<1%	415	$5K
82947		<1%	1,781	$4K
C1773	Retrieval device, insertable (used to retrieve fractured medical devices)	<1%	207	$4K
87150		<1%	163	$4K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	2,396	$4K
82465		<1%	1,701	$4K
J9267	Injection, paclitaxel, 1 mg	<1%	89	$4K
73700		<1%	17	$4K
82107		<1%	79	$4K
93225		<1%	48	$4K
88173		<1%	425	$4K
87625		<1%	263	$4K
88189		<1%	131	$4K
87206		<1%	1,469	$4K
82525		<1%	371	$4K
88280		<1%	254	$4K
J2720	Injection, protamine sulfate, per 10 mg	<1%	595	$4K
95819		<1%	12	$4K
89051		<1%	2,055	$4K
80195		<1%	550	$4K
85303		<1%	340	$4K
87563		<1%	141	$4K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,599	$4K
73080		<1%	937	$4K
72170		<1%	764	$4K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	413	$4K
87430		<1%	1,321	$4K
72158		<1%	27	$4K
87046		<1%	643	$4K
Q3014	Telehealth originating site facility fee	<1%	140	$3K
85300		<1%	371	$3K
87640		<1%	166	$3K
86015		<1%	33	$3K
29125		<1%	12	$3K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	1,486	$3K
0134A		<1%	76	$3K
73590		<1%	1,177	$3K
85097		<1%	51	$3K
36416		<1%	222	$3K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,886	$3K
86361		<1%	848	$3K
84166		<1%	216	$3K
J2800	Injection, methocarbamol, up to 10 ml	<1%	624	$3K
81241		<1%	234	$3K
84145		<1%	1,021	$3K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	579	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,322	$3K
86945		<1%	242	$3K
96116		<1%	13	$3K
86757		<1%	93	$3K
73140		<1%	387	$3K
84134		<1%	288	$3K
86738		<1%	114	$3K
J3360	Injection, diazepam, up to 5 mg	<1%	517	$3K
85246		<1%	140	$3K
73090		<1%	765	$3K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	69	$3K
83718		<1%	644	$3K
87341		<1%	286	$3K
90670		<1%	13	$3K
70544		<1%	24	$3K
J0280	Injection, aminophyllin, up to 250 mg	<1%	355	$3K
76377		<1%	93	$2K
84132		<1%	1,083	$2K
85347		<1%	3,027	$2K
85576		<1%	56	$2K
82374		<1%	1,048	$2K
93226		<1%	48	$2K
84295		<1%	1,021	$2K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,014	$2K
81240		<1%	209	$2K
0031A		<1%	74	$2K
87581		<1%	219	$2K
86352		<1%	31	$2K
82435		<1%	1,022	$2K
74018		<1%	648	$2K
72157		<1%	15	$2K
84255		<1%	76	$2K
87486		<1%	198	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	283	$2K
J2305	Injection, nitroglycerin, 5 mg	<1%	600	$2K
84520		<1%	1,038	$2K
96368		<1%	294	$2K
95714		<1%	34	$2K
86593		<1%	663	$2K
87210		<1%	964	$2K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	408	$2K
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	13	$2K
J8540	Dexamethasone, oral, 0.25 mg	<1%	1,166	$2K
82657		<1%	96	$2K
87529		<1%	39	$2K
86258		<1%	29	$2K
90656		<1%	147	$2K
0072A		<1%	50	$2K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	577	$2K
84478		<1%	609	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,048	$2K
85307		<1%	125	$2K
88271		<1%	40	$2K
95874		<1%	160	$2K
0071A		<1%	69	$2K
81206		<1%	24	$2K
93923		<1%	12	$1K
88275		<1%	28	$1K
81002		<1%	544	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	86	$1K
84238		<1%	31	$1K
87449		<1%	182	$1K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	293	$1K
84080		<1%	115	$1K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	12	$1K
86215		<1%	97	$1K
0051A		<1%	28	$1K
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	93	$1K
88331		<1%	53	$1K
88387		<1%	181	$1K
J9250	Methotrexate sodium, 5 mg	<1%	635	$1K
76885		<1%	12	$1K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	221	$1K
95887		<1%	26	$1K
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	<1%	891	$1K
J3411	Injection, thiamine hcl, 100 mg	<1%	804	$1K
82552		<1%	745	$980.61
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	289	$940.26
87255		<1%	38	$887.04
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	77	$873.87
76828		<1%	43	$869.66
J3489	Injection, zoledronic acid, 1 mg	<1%	12	$840.16
86692		<1%	54	$833.91
83014		<1%	107	$831.10
83519		<1%	43	$800.69
83605		<1%	577	$800.10
96132		<1%	13	$797.52
88365		<1%	12	$796.36
86231		<1%	26	$758.76
97014		<1%	12	$734.95
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	129	$732.37
88311		<1%	159	$720.48
87185		<1%	166	$715.79
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	80	$713.13
82009		<1%	296	$702.33
73552		<1%	218	$675.70
85245		<1%	38	$666.66
J7644	Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	<1%	2,995	$657.63
80183		<1%	62	$635.03
86063		<1%	121	$623.20
94618		<1%	24	$614.64
82945		<1%	151	$611.83
80178		<1%	115	$603.21
86880		<1%	41	$581.52
86325		<1%	26	$575.21
81270		<1%	27	$569.70
97010		<1%	57	$550.19
88177		<1%	12	$548.97
80320		<1%	1,115	$542.90
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	89	$533.73
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	29	$528.67
82330		<1%	68	$527.74
91300		<1%	7,909	$523.33
88285		<1%	26	$516.92
80321		<1%	17	$509.29
84157		<1%	188	$480.84
82595		<1%	86	$475.79
0053A		<1%	12	$471.87
86340		<1%	41	$466.97
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,193	$459.84
80349		<1%	188	$439.20
72128		<1%	12	$426.23
80348		<1%	185	$424.20
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	648	$387.62
87521	Neg quan hep c or qual rna	<1%	12	$378.96
81015		<1%	1,216	$354.52
87275		<1%	98	$350.47
81291		<1%	13	$334.54
J0780	Injection, prochlorperazine, up to 10 mg	<1%	114	$331.75
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	111	$329.22
0107U		<1%	60	$323.20
76376		<1%	104	$319.38
86308		<1%	95	$309.45
87324		<1%	31	$304.65
J2060	Injection, lorazepam, 2 mg	<1%	615	$300.79
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each	<1%	50	$296.52
85018		<1%	140	$295.63
J1940	Injection, furosemide, up to 20 mg	<1%	253	$289.37
73560		<1%	16	$282.60
82010		<1%	460	$280.04
82340		<1%	57	$274.45
G0475	Hiv antigen/antibody, combination assay, screening	<1%	13	$260.04
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	108	$251.72
J1630	Injection, haloperidol, up to 5 mg	<1%	360	$249.65
82530		<1%	15	$249.63
80230		<1%	14	$241.07
85014		<1%	139	$239.07
77062		<1%	18	$232.48
85247		<1%	12	$230.60
J1836	Injection, metronidazole, 10 mg	<1%	284	$216.39
73010		<1%	38	$212.00
73060		<1%	152	$203.86
82542		<1%	12	$195.76
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	44	$192.10
G0009	Administration of pneumococcal vaccine	<1%	14	$187.69
J1921	Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg	<1%	15	$187.62
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	4,038	$173.51
81050		<1%	53	$162.00
80329		<1%	66	$158.66
91312		<1%	512	$157.50
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	14	$152.31
82270		<1%	75	$139.78
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	1,443	$139.40
82365		<1%	13	$133.00
82104		<1%	13	$122.09
90749		<1%	13	$116.55
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	120	$114.11
85660		<1%	33	$106.32
J9260	Injection, methotrexate sodium, 50 mg	<1%	33	$105.16
J7507	Tacrolimus, immediate release, oral, 1 mg	<1%	179	$103.57
96523		<1%	48	$102.82
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,333	$95.74
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	306	$88.51
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	150	$76.43
91305		<1%	262	$74.41
94728		<1%	20	$68.42
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	27	$53.49
J7999	Compounded drug, not otherwise classified	<1%	1,228	$46.88
80346		<1%	27	$44.60
87184		<1%	13	$43.27
88300		<1%	38	$38.41
87541		<1%	116	$35.09
J1953	Injection, levetiracetam, 10 mg	<1%	12	$33.87
91307		<1%	114	$33.64
S0077	Injection, clindamycin phosphate, 300 mg	<1%	16	$32.70
J1597	Injection, glycopyrrolate (glyrx-pf), 0.1 mg	<1%	159	$27.73
J7614	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg	<1%	64	$26.02
J1171	Injection, hydromorphone, 0.1 mg	<1%	112	$9.88
91313		<1%	32	$9.61
J0173	Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg	<1%	23	$8.54
Q9954	Oral magnetic resonance contrast agent, per 100 ml	<1%	15	$2.70
91303		<1%	72	$2.00
J7517	Mycophenolate mofetil, oral, 250 mg	<1%	31	$1.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	24	$1.00
G0124	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician	0%	429	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	150	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	143	$0.00
76857		0%	24	$0.00
99080		0%	550	$0.00
0202U	Oncology (prostate), multianalyte, gene expression profiling	0%	17	$0.00
C8937	Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)	0%	12	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	12	$0.00
64494		0%	15	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	12	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	31	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	28	$0.00
67320		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSMITH, WESLEY (VP REVENUE CYCLE)

Same official

Other billing entities under SMITH, WESLEY

Full network →

Provider	Location	Paid
Nyu Langone Hospitals	Brooklyn, NY	$303.18M
Nyu Langone Hospitals	New York, NY	$117.59M
Nyu Langone Hospitals	Mineola, NY	$69.77M
Nyu Langone Hospitals	New York, NY	$32.22M
Nyu Langone Hospitals	New York, NY	$3.50M
Nyu Langone Hospitals	Brooklyn, NY	$453K
Nyu Langone Hospitals	Brooklyn, NY	$99K
Nyu Langone Hospitals	Brooklyn, NY	$9K
Nyu Hospitals Center	New York, NY	$55.44

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.